Skip to main content
SpringerLink
Log in

Strengere eisen voor nieuwe antidiabetica gewenst

  • Journaal
  • Published:
Tijdschrift voor praktijkondersteuning Aims and scope

Samenvatting

Er worden veel nieuwe antidiabetica ontwikkeld, maar er is kritiek op de bestaande beoordelingsprocedures van die medicijnen. Dat kan beter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  1. Naci H, et al. Rethinking the appraisal and approval of drugs for type 2 diabetes. BMJ 2015;353:h5260.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.bsl.nl

    Tjerk Wiersma

Authors
  1. Tjerk Wiersma
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Naci H, et al. Rethinking the appraisal and approval of drugs for type 2 diabetes.

BMJ 2015;353:h5260.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wiersma, T. Strengere eisen voor nieuwe antidiabetica gewenst. Tijdschr Prakt Ondersteun 11, 35 (2016). https://doi.org/10.1007/s12503-016-0017-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12503-016-0017-3

Search

Navigation